1. Vane J.R. (1971). Inhibition of prostaglandin biosynthesis as a mechanism of action of aspirin-like drugs. Nature (London) New Biol., 231, 232–235
2. Main, I.H.M. and Whittle, B.J.R. (1974). Prostaglandins and prostaglandin synthetase inhibitors in gastrointestinal function and disease. In Robinson, H.J. and Vane, J.R. (eds.) Prostaglandin Synthetase Inhibitors, pp. 363–372. (New York: Raven Press)
3. Robert, A., Nezamins, J.E. and Phillips, J.P. (1968). Effects of prostaglandin E1 on gastric secretion and ulcer formation in the rat. Gastroenterology, 55, 481–487
4. Bennett, A., Eley, K.G. and Scholes, G.B. (1968). Effects of prostaglandins E1 and E2 on human, guinea pig and rat isolated small intestine. Br. J. Pharmacol., 34, 630–638
5. Collier, H.O.J. (1974). Prostaglandin synthetase inhibitors and the gut. In Robinson, H.J. and Vane, J.R. (eds.) Prostaglandin Synthetase Inhibitors, pp. 121–133. (New York: Raven Press)